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ABSTRACT
Background and the purpose of the study: Cerebral ischemia is one of the main causes of long 
term disability and death in aged populations. Many herbal drugs and extracts have been used 
for the treatment of cerebral ischemia induced insults. This study was designed to investigate 
the protective effect of Semelil (ANGIPARS™), a new herbal drug, on focal cerebral ischemia 
in male rats.
Material and methods: Male rats were divided into five groups: sham-operated, ischemic 
animals treated with distilled water as vehicle, ischemic animals treated with 1, 10 and 100 
mg/kg of Semilil respectively. Middle cerebral artery occlusion (MCAO) model was used in 
NMRI rats and neuronal injury analyzed in hippocampal CA1 sector after 48 hrs of Middle 
Cerebral Artery (MCAO).     
Results: Results of this study showed that treatment with semelil attenuated ischemic damages 
and has positive effects on focal cerebral ischemia.
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INTRODUCTION
In spite of many efforts, cerebral ischemia or stroke 
still represents the third leading cause of death and 
the most important source of long-term disability 
in the world. Many herbal drugs including Nigella 
sativa L. extracts (1); green tea extract (2) and date 
fruit extract (3) have been used for the treatment of 
this disease.
Melilotus  officinalis has been introduced as a 
component of a new drug by trade name of Semilil 
(ANGIPARS™). In vivo studies in rodents and 
dogs and also in vitro studies in some established 
cell lines have approved its safety (4-6). Previous 
studies have shown beneficial effects of Semilil 
such as improvement of blood circulation, 
reduction  of  inflammation,  improvement  of 
lymphedema, and immune system (7-10). 
Results of clinical trials on Semilil indicated its 
safety and efficacy in human diabetic foot ulcer 
(11-13). This drug has been found to have strong 
antioxidant components such as 7 hydroxy 
coumarin, flavonoids, and oleanene glucuronide 
(9, 14). Since some of these properties (anti-
inflammatory  and  antioxidant)  may  be  useful 
in the treatment of the damages that inevitably 
followed by cerebral ischemia, in this study the 
protective effects of Semilil on focal cerebral 
ischemia in male rats was investigated.
MATERIAlS AND METhODS
Semelil herbal extract (ANGIPARS™) was 
generously prepared and delivered by ParsRoos       
Co. (Tehran, Iran).
NMRI male rats weighing 220-280 g were used in 
accordance with Kerman Neuroscience Research 
Center (EC/KNRC/88-6) legislation on the use and 
care of laboratory animals. Animals were clinically 
normal, free of obvious infection or inflammation.
The animals were divided into 5 different groups: 
sham-operated group (n=4), ischemic animals 
treated with distilled water as vehicle (Ischemia + 
Vehicle) (n=5), ischemic animals treated with 1, 10 
and 100 mg/kg of Semilil (Ischemia + 1 mg/kg of 
Semilil, n=4; Ischemia + 10 mg/kg of Semilil, n=4; 
Ischemia + 100 mg/kg of Semilil, n=31). Semilil 
was injected intraperitoneally 30 min after induction 
of ischemia. 
Transient focal cerebral ischemia
The MCAO was induced by using an intraluminal 
monofilament model (15). In brief, the animals were 
anesthetized with chloral hydrate (Merck, 400 mg/kg), 
placed in supine position on a heated pad, with body 
temperature maintained at 37±0.5°C using rectal 
thermometer. Under the operating microscope, the 
right common carotid artery, external and internal 266 Effects of Semelil (ANGIPARS™)
carotid arteries were exposed. After blocking all 
branches of the external carotid artery and extra cranial 
branches of the internal carotid artery, a 3-0 nylon 
intraluminal filament was introduced into the cervical 
internal carotid artery and advanced intracranially to 
block blood flow into the Middle Cerebral Artery 
(MCA).  After  30  min,  the  intraluminal  filament 
was withdrawn and blood flow resumed (Ischemia/
Reperfusion) (I/R). After full recovery, neurological 
evaluation was performed to ensure occurrence of 
MCAO, and animals without clinical signs were 
then excluded from the experiment.
Histological assessments
The animals were anesthetized with chloral hydrate 
(Merck) (400 mg/kg BW, intraperitoneally) and 
killed by cardiac perfusion of saline followed by 
10% formaldehyde in 0.1 M sodium phosphate-
buffered solution (PBS, pH of 7.5). Subsequent to 
perfusion, the brains were carefully removed and 
stored in the perfusion fixation at 4°C for a minimum 
of 24 hrs. The brains were sectioned coronally (5 
μm) by using a microtome set. Brain sections were 
subjected to H&E and immunhistochemistry (IHC) 
by using TUNEL staining. Neuronal damage was 
calculated based on the number of degenerated 
neurons to that of both surviving and degenerated 
neurons in 3 separate areas of the CA1 sector at a 
magnification of X400 (medial, middle and lateral 
parts, Fig 1) (16). 
TUNEL staining
The terminal deoxynucleotidyl transferase (TdT)-
mediated in situ dUTP nick end-labeling (TUNEL) 
assay was utilized on the brain sections using the cell 
death detection Kit POD (Roche; Indianapolis, IN). A 
dark brown color indicating DNA breaks developed 
after incubation with DAB (3-3΄-diamonobenzidine 
tetrachloride) and hydrogen peroxide. The method 
was used to verify the cell death in hippocampal 
CA1 sector (17).
Statistical analyses 
The data were presented as mean ± SEM. One way 
ANOVA and Tukey-Kramer multiple post hoc test 
was used to compare data between different groups 
and p<0.05 was considered statistically significant 
difference.
RESUlTS
Light microscopic evaluations showed morpho-
logical changes in the CA1 sector after 48 hrs of 
MCAO. Most of pyramidal neurons of the area 
showed marked injury due to 30 min ischemia 
and 48 hrs reperfusion. In the sham group, the 
morphology of neurons in CA1 sector was normal. 
Meanwhile, most of the neurons in ischemic group 
showed degenerative changes including: extensively 
dark piknotic nuclei and shrunken cytoplasm. In 
experimental groups, the severity of degenerative 
changes in nucleus and cytoplasm was lesser than 
that in ischemic groups (Fig 2).
Neuronal  counting  showed  significant  difference 
between ischemic + 1 mg/kg of Semilil (p<0.05) 
and ischemic + 10 mg/kg of Semilil (p<0.05) groups 
compared to vehicle group.
Due to the high mortality rate of the animals in 
Ischemia + 100 mg/kg of Semilil group, neuronal 
counting was not performed for this group.
Neuronal injury in the CA1 area following ischemia/
reperfusion was also examined by TUNEL method. 
There were no TUNEL positive (+) cells in the CA1 area 
in the sham-operated group but many TUNEL posetive 
cells were detected in the vehicle group (Fig 3).
Figure 1. Photomicrograph of coronal section of rat hippocampus. 
The box indicates the area which was analyzed in the study.
Figure 2. Protective effects of Semelil (ANGIPARS™) 
in the CA1 hippocampal neurons of rats after transient 
cerebral ischemia. Histopathological changes in CA1 area 
of hippocampus: (A) sham-operated (small arrow show the 
surviving neuron), (B) vehicle (large arrow shows degenerated 
neuron), (C) 1mg/kg of Semelil treated group, and (D) 10mg/kg 
of Semelil treated group. Magnification × 400. H&E staining.267 Effects of Semelil (ANGIPARS™)
carotid arteries were exposed. After blocking all 
branches of the external carotid artery and extra cranial 
branches of the internal carotid artery, a 3-0 nylon 
intraluminal filament was introduced into the cervical 
internal carotid artery and advanced intracranially to 
block blood flow into the Middle Cerebral Artery 
(MCA).  After  30  min,  the  intraluminal  filament 
was withdrawn and blood flow resumed (Ischemia/
Reperfusion) (I/R). After full recovery, neurological 
evaluation was performed to ensure occurrence of 
MCAO, and animals without clinical signs were 
then excluded from the experiment.
Histological assessments
The animals were anesthetized with chloral hydrate 
(Merck) (400 mg/kg BW, intraperitoneally) and 
killed by cardiac perfusion of saline followed by 
10% formaldehyde in 0.1 M sodium phosphate-
buffered solution (PBS, pH of 7.5). Subsequent to 
perfusion, the brains were carefully removed and 
stored in the perfusion fixation at 4°C for a minimum 
of 24 hrs. The brains were sectioned coronally (5 
μm) by using a microtome set. Brain sections were 
subjected to H&E and immunhistochemistry (IHC) 
by using TUNEL staining. Neuronal damage was 
calculated based on the number of degenerated 
neurons to that of both surviving and degenerated 
neurons in 3 separate areas of the CA1 sector at a 
magnification of X400 (medial, middle and lateral 
parts, Fig 1) (16). 
TUNEL staining
The terminal deoxynucleotidyl transferase (TdT)-
mediated in situ dUTP nick end-labeling (TUNEL) 
assay was utilized on the brain sections using the cell 
death detection Kit POD (Roche; Indianapolis, IN). A 
dark brown color indicating DNA breaks developed 
after incubation with DAB (3-3΄-diamonobenzidine 
tetrachloride) and hydrogen peroxide. The method 
was used to verify the cell death in hippocampal 
CA1 sector (17).
Statistical analyses 
The data were presented as mean ± SEM. One way 
ANOVA and Tukey-Kramer multiple post hoc test 
was used to compare data between different groups 
and p<0.05 was considered statistically significant 
difference.
RESUlTS
Light microscopic evaluations showed morpho-
logical changes in the CA1 sector after 48 hrs of 
MCAO. Most of pyramidal neurons of the area 
showed marked injury due to 30 min ischemia 
and 48 hrs reperfusion. In the sham group, the 
morphology of neurons in CA1 sector was normal. 
Meanwhile, most of the neurons in ischemic group 
showed degenerative changes including: extensively 
dark piknotic nuclei and shrunken cytoplasm. In 
experimental groups, the severity of degenerative 
changes in nucleus and cytoplasm was lesser than 
that in ischemic groups (Fig 2).
Neuronal  counting  showed  significant  difference 
between ischemic + 1 mg/kg of Semilil (p<0.05) 
and ischemic + 10 mg/kg of Semilil (p<0.05) groups 
compared to vehicle group.
Due to the high mortality rate of the animals in 
Ischemia + 100 mg/kg of Semilil group, neuronal 
counting was not performed for this group.
Neuronal injury in the CA1 area following ischemia/
reperfusion was also examined by TUNEL method. 
There were no TUNEL positive (+) cells in the CA1 area 
in the sham-operated group but many TUNEL posetive 
cells were detected in the vehicle group (Fig 3).
Figure 1. Photomicrograph of coronal section of rat hippocampus. 
The box indicates the area which was analyzed in the study.
Figure 2. Protective effects of Semelil (ANGIPARS™) 
in the CA1 hippocampal neurons of rats after transient 
cerebral ischemia. Histopathological changes in CA1 area 
of hippocampus: (A) sham-operated (small arrow show the 
surviving neuron), (B) vehicle (large arrow shows degenerated 
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Figure 3. Immunohistochemical analysis of TUNEL in CA1 area of rat hippocampus for control and sham-operated (A), Ischemic (B), 
treated group with 1 mg/kg of Semelil (C) and treated group with 10 mg/kg of Semelil (D). Arrow show the apoptotic cells. Magnification 
× 400. TUNEL staining.
� 8
and D), treated group with 10 mg/kg of Semelil (E). Arrow shows the apoptotic cells.  
Magnification × 400. TUNEL staining.
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Fig.4 Effect of Semelil on hippocampal CA1 cell death induced by 30 min MCAO 
followed by 48 hrs reperfusion. Results are expressed as mean ± S.E and data were 
analyzed by One-way ANOVA followed by Tukey-Kramer multiple comparisons test. 
Significantly different from control. ***
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Figure 4. Effect of Semelil on hippocampal CA1 cell death induced by 30 min MCAO followed by 48 hrs reperfusion. Results are 
expressed as mean ± S.E and data were analyzed by One-way ANOVA followed by Tukey-Kramer multiple comparisons test.
***Significantly different from control. 268 Effects of Semelil (ANGIPARS™)
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GROUP (ALL)* (DC) ** (DC/ALL×100) ***
Sham-operated 328.75 25 7.68
Ischemic + Vehicle 304.75 245 79.97
Ischemic+1mg/kg Semelil 340.33 74.66 21.87#
Ischemic+10mg/kg Semelil 328.00 151.5 48.06#
Six group (n=6) were counted. 
*Average numbers of all of neurons  
**Average numbers of the degenerated cells (DC) 
*** Percent average of the cells death (DC/ All×100)
#P<0.05 for Semelil (1 and 10 mg/kg)
Table 1. Effect of Semelil on hippocampal CA1 neuronal death in Middle Cerebral Artery Occlusion rats.
DISCUSSION
To our knowledge, this is the first study that provided 
evidence of effectiveness of Semilil in cerebral 
ischemia in a rat I/R model.
selenium is a new drug product containing herbal 
extract  with  known  beneficial  effects  especially 
on diabetic foot. Some of its components are urea, 
selenium, fructose and Melilotus officinalis extract 
as declared by manufacturer. Previous studies have 
shown that urea could improve cerebral blood 
flow and oxygenation and it may work the same as 
manitol, a known neuroprotective (18). Selenium 
is a known potent antioxidant agent that may have 
neuroprotective activity (19). Melilotus  officinalis 
extract could reduce activation of circulating 
phagocytes  and  it  has  anti  inflammatory,  anti-
edematous and antioxidants effects. (8, 9, 14). On 
the other hand, experimental evidences have shown 
that fructose can induce inflammatory response that 
may worsen the ischemic damage (20).
Brain is almost absolutely dependent on the 
continuous flow of oxygen and glucose to undergo 
oxidative phosphorylation for energy production. 
The first result of cerebral blood flow reduction is 
decline of substrates, mainly oxygen and glucose 
that causes accumulation of lactate via anaerobic 
glycolysis. Acidosis may augment free radical 
formation, interfering with intracellular protein 
synthesis and worsen ischemic brain damages (21). 
In addition, re-perfusion in the brain after ischemia 
induces  an  inflammatory  response  that  may 
exacerbate initial levels of tissue damage. There are 
a number of possible mechanisms by which post-
ischemic inflammation could contribute to damages, 
including production of toxic mediators such as 
NO  by  activated  inflammatory  cells  and  vascular 
occlusion by neutrophils.
It has been reported that inhibition of reactive oxygen 
species  generation,  inflammatory  cell  activation, 
pro-inflammatory  cytokine  production,  apoptotic 
gene induction provides neuroprotective effects 
against cerebral I/R injury (22).
Semilil has many components with neuroprotective 
properties that may explain the observed effects. At 
the present time, the exact protective mechanism 
of Semilil on cerebral ischemia is not known. 
This study was just concentrated on general effect 
of Semilil on neuronal survival in hippocampus 
and not its mechanism. Further studies focusing 
on microcirculation of prepost reperfusion and 
inflammatory factors are required to find the related 
mechanisms. 
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